TDOC
TDOC
NYSE · Health Care

Teladoc Health Inc

$6.30
+0.02 (+0.32%)
Financial Highlights (FY 2026)
Revenue
2.66B
Net Income
-210,561,860
Gross Margin
69.5%
Profit Margin
-7.9%
Rev Growth
+1.7%
D/E Ratio
0.72
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.66B 2.62B 196.92M 169.36M
Gross Profit 1.85B 1.82B 118.05M 101.52M
Operating Income -276,292,338 -244,554,587 28.47M 21.48M
Net Income -210,561,860 -186,374,581 22.43M 19.47M
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Rev Growth +1.7% +1.7% +7.3% +5.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 238.42M 238.42M 331.89M 372.61M
Total Equity 332.07M 332.07M 654.10M 617.48M
D/E Ratio 0.72 0.72 0.51 0.60
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 106.28M 99.30M 39.52M 34.03M
Free Cash Flow 11.14M 11.84M